Showing results (501-510 of 575) with videos related to

Sort By:
Pageof 58
Frontiers in Immunology|September 7, 2021
Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine NeuroblastomaPaul D Bates, Alexander L Rakhmilevich, Monica M Cho, et al.
Terapevticheskii Arkhiv|February 1, 2019
Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017)E V Vinnitskaya, Yu G Sandler, I G Bakulin, et al.
Cancer Research|May 29, 2025
CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast CancerEui-Jun Kim, Yidan Wang, Yu-Lin Chen, et al.
The Journal of Biological Chemistry|July 1, 2018
Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9Tewfik Hamidi, Anup Kumar Singh, Nicolas Veland, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2018
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell TherapyHaneen Shalabi, Pamela L Wolters, Staci Martin, et al.
Molecular Therapy. Methods & Clinical Development|March 20, 2018
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical TrialsHenrieta Fraser, Niloufar Safinia, Nathali Grageda, et al.
Molecular Therapy. Advances|May 18, 2026
A single-cell multi-omics assay for simultaneous measurement of vector copy number and protein expression in CAR T cellsYilong Yang, Saurabh Parikh, Chieh-Yuan Li, et al.
Alimentary Pharmacology & Therapeutics|August 4, 2015
Liver injury is associated with mortality in sickle cell diseaseJ J Feld, G J Kato, C Koh, et al.
Leukemia|December 16, 2024
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemiaTommaso Balestra, Lisa M Niswander, Asen Bagashev, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cellsSteven A Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, et al.
Pageof 58